Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: Effect of propionyl-L-carnitine

Muscle and Nerve

Volumn 20, Issue 9, 1997, Pages 1115-1120

  Brevetti, Gregorio ^a   Fanin, Marina ^b   De Amicis, Vincenzo ^a   Carrozzo, Rosalba ^b   Lello, Francesco D I ^a   Marione, Vincenzo Domenico ^a   Angelini, Corrado ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Coronary artery disease; Energy metabolism; Physical deconditioning; Propionyl L carnitine; Skeletal muscle

Indexed keywords

CARNITINE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; GLYCOGEN; PROPIONYLCARNITINE; SUCCINATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVITY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE HYPOTONIA; MUSCLE METABOLISM; PRIORITY JOURNAL; SKELETAL MUSCLE;

CARNITINE; CONDITIONING (PSYCHOLOGY); CORONARY DISEASE; EXERCISE; GLYCOGEN; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; REFERENCE VALUES;

EID: 0030872535     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199709)20:9<1115::AID-MUS4>3.0.CO;2-B     Document Type: Article

References (16)

1. Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini A, Attisano T, Ambrosio G, Siliprandi N, Angelini C: Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation 1988;77:767-773.
2. Brevetti G, Angelini C, Rosa M, Carrozzo R, Perna S, Corsi M, Matarazzo A, Marcialis A: Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation 1991; 84:1490-1495.
3. Brevetti G, Perna S, Sabbà C, Rossini A, Scotto Di Uccio V, Berardi E, Godi L: Superiority of propionyl-L-carnitine versus L-carnitine in improving walking capacity in patients with peripheral vascular disease. An acute, intravenous, double-blind, cross-over study. Eur Heart J 1992;13:251-255.
4. Brevetti G, Perna S, Sabbà C, Marione YD, Condorelli M: Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol 1995;26:1411-1416.
5. Broderick TL, Di Domenico D, Shug AL, Paulson DJ: L-propionylcarnitine effects on cardiac carnitine contents and function in secondary carnitine deficiency. Can J Physiol Pharmacol 1995;73:509-514.
6. Caderblad G, Lindstedt S: A method for determination of carnitine in the picomole range. Clin Chim Acta 1972;37: 235-243.
7. Corsico N, Nardoni A, Lucreziotti MR, Spagnoli LG, Pesce D, Aureli T, Di Cocco ME, Miccheli A, Conti F, Arrigoni A, Martelli E: Effect of propionyl-L-carnitinc in a rat model of peripheral arteriopathy: a functional, histologic and NMR spectroscopy study. Cardiovasc Drug Ther 1993;7:241-251.
8. Coyle EF, Martin WH III, Bloomfield SA, Lowry OH, Holloszy JO: Effects of detraining on responses to submaximal exercise. J Appl Physiol 1985;59:853-859.
9. Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H: Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-1759.
10. Dunningan A, Staley N, Smith S, Pierpont M, Judd D, Benditt D, Benson D: Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol 1987; 10:608-618.
11. Frisk-Holmberg M, Jorfeldt L, Juhlin-Dannfelt A, Karlsson J: Leg blood flow during exercise in man in relation to muscle fiber composition. Acta Physiol Scand 1981;112:339-342.
12. Green HJ, Thomson JA, Daub BD, Ranney DA: Biochemical and histochemical alterations in skeletal muscle in man during a period of reduced activity. Can J Physiol Pharmacol 1980; 58:1311-1316.
13. Hassid WZ, Abraham S: Chemical procedures for analysis of polysaccharides. Methods Enzymol 1957;3:34.
14. Karlsson J: Onset of blood lactate accumulation exercise capacity, skeletal muscle fibers and metabolism before and after coronary artery bypass grafting. Am J Cardiol 1988;62:108E-114E.
15. Karlsson J, Diamant B, Folkers K, Astrom H, Gunnes S, Liska J, Semb B: Ischaemic heart disease, skeletal muscle fibers and exercise capacity. Eur Heart J 1992; 13:758-762.
16. Larsson L, Ansved T: Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man. Muscle Nerve 1985;8: 714-722.